How reliable is the short synacthen test for the investigation of the hypothalamic-pituitary-adrenal axis?

Department of Diabetes and Endocrinology, City General Hospital, Stoke on Trent, Staffordshire, UK.

The best test for the assessment of the hypothalamic-pituitary-adrenal (HPA) axis remains a matter of controversy. We compared the performance of the short synacthen test (SST, 250 microg) with the insulin stress test (IST) to assess the reliability of the former as a first line test. Patients with pituitary disease underwent both the SST and the IST. The results in patients who had both tests within 4 weeks of each other, and where these were not separated by a therapeutic intervention, were compared. Basal, 30 and 60 min cortisol levels were obtained from the SST. Basal and maximal cortisol level after adequate hypoglycaemia (glucose<2.2 mmol/l) were recorded for the IST. Sixty-nine paired test results were available for analysis. With a 30 min 'pass' plasma cortisol value of 500 nmol/l on the SST, 7/69 (10%) patients who passed the SST failed the IST set at a 'pass' maximum value of 500 nmol/l. At a 'pass' cortisol value of 600 nmol/l on the SST, 3/69 (4%) who passed the SST failed the IST. Assuming the IST as the gold standard, the sensitivity of an SST 'pass' of 600 nmol/l is 85% with a specificity of 96%. During the conventional dose SST (250 microg) a 30 min plasma cortisol value of 600 nmol/l is more reliable than a value of 500 nmol/l, and using the former criterion the SST can safely be used as a first line test for the evaluation of the HPA axis in patients with pituitary disease. However, if the result is borderline or there is clinical suspicion of mild hypocorticotrophism an IST or other test of the HPA axis may be warranted.

This article has been cited by other articles:

				S. Siyambalapitiya, V. Ibbotson, A. Doane, E. Ghigo, M. J. Campbell, and R. J. Ross Combining Growth Hormone Releasing Hormone-Arginine and Synacthen Testing Diminishes the Cortisol Response J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 853 - 856. [Abstract] [Full Text] [PDF]

				A. Agha, J. W. Tomlinson, P. M. Clark, G. Holder, and P. M. Stewart The Long-Term Predictive Accuracy of the Short Synacthen (Corticotropin) Stimulation Test for Assessment of the Hypothalamic-Pituitary-Adrenal Axis J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 43 - 47. [Abstract] [Full Text] [PDF]

				M. P. Nasrallah and B. M. Arafah The Value of Dehydroepiandrosterone Sulfate Measurements in the Assessment of Adrenal Function J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5293 - 5298. [Abstract] [Full Text] [PDF]

				R. I. Dorin, C. R. Qualls, and L. M. Crapo Diagnosis of Adrenal Insufficiency Ann Intern Med, August 5, 2003; 139(3): 194 - 204. [Abstract] [Full Text] [PDF]

				M. Schmiegelow, U. Feldt-Rasmussen, A. K. Rasmussen, M. Lange, H. S. Poulsen, and J. Muller Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients Treated with Radiotherapy and Chemotherapy for Childhood Brain Tumor J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3149 - 3154. [Abstract] [Full Text] [PDF]

				W. J. Inder and P. J. Hunt Glucocorticoid Replacement in Pituitary Surgery: Guidelines for Perioperative Assessment and Management J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2745 - 2750. [Abstract] [Full Text] [PDF]

				R. Karlsson, J. Kallio, K. Irjala, S. Ekblad, J. Toppari, and P. Kero Adrenocorticotropin and Corticotropin-Releasing Hormone Tests in Preterm Infants J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4592 - 4595. [Abstract] [Full Text]

				T. A. M. Abdu, T. A. Elhadd, R. Neary, and R. N. Clayton Comparison of the Low Dose Short Synacthen Test (1 {micro}g), the Conventional Dose Short Synacthen Test (250 {micro}g), and the Insulin Tolerance Test for Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients with Pituitary Disease J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 838 - 843. [Abstract] [Full Text]